Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesReimbursement/Payment PolicyProvidence Medicare Advantage Prior Auth Policy | …
    Ask Trek AI about this page
    CurrentProvidence Health PlanPolicy N/A

    Providence Medicare Advantage Plans 2026 Prior Authorization Criteria for Part B Drugs

    Customize your policy alerts

    Sign up for all Providence Health Plan policy alerts

    Know when Providence Health Plan releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Prior authorization requirements for certain Medicare Part B–covered drugs for Providence Medicare Advantage Plans effective 7/1/2026; applies to members and prescribing providers who seek coverage for listed Part B drugs.

    Policy Summary
    PayerProvidence Health Plan
    PolicyProvidence Medicare Advantage Plans 2026 Prior Authorization Criteria for Part B Drugs
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateJul 1, 2026
    Next Review Date
    Key ActionObtain prior authorization from the plan before administering listed Part B drugs to ensure coverage.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    100+
    Part B drugs listed
    20+Listed drugs & codes in excerpt
    severalEntries with effective-after dates
    Phone & hoursContact info availability

    Medicare Part B Drug Prior Authorization — Covered Criteria Index

    Listed Part B drugs and link to criteria

    The document lists Medicare Part B drugs subject to prior authorization and provides a link to view the specific prior authorization criteria for each listed drug.

    Listed Part B drugs are subject to prior authorization and include a 'click to view' link to the drug-specific policy criteria.

    Drug listing and link directory

    Indexed medications subject to prior authorization; each entry includes the HCPCS/Q-code, medication name, and a 'Click to view' link to the individual prior authorization criteria.

    Medication listings are presented as code + medication name + 'Click to view' link (no full criteria text appears in this excerpt).

    Part B drug index entries

    Enumeration of procedure/HCPCS codes mapped to medication names with document links to the drug-specific prior authorization criteria; some entries include an 'effective date (if after 1/1/2026)'.

    Index entries map Procedure Code(s) to: 1 = Medication Name; 2 = Document Link (Click to view); 3 = Effective Date (if after 1/1/2026).

    Examples

    • J9223 — Zepzelca (Lurbinectedin) — Click to view
    • J3399 — Zolgensma (Onasemnogene abeparvovec-xioi) — Click to view
    • J9332 — Vyvgart (Efgartigimod alfa) — Click to view

    HCPCS / CPT / Procedure Code Listings

    Sample listed HCPCS/Codes with drug namesHCPCSCovered
    Q2055Abecma (Idecabtagene vicleucel)
    J9264Abraxane (Paclitaxel protein-bound particles)
    J3262Actemra (Tocilizumab)
    J0791Adakveo (Crizanlizumab-tmca)
    J9042Adcetris (Brentuximab vedotin)
    J9029Adstiladrin (Nadofaragene firadenove)
    Sample HCPCS codes in listHCPCS
    J9394Fulvestrant (Fresenius Kabi) — HCPCS code shown
    J9393Fulvestrant (Teva) — HCPCS code shown
    J9331Fyarro (Sirolimus protein-bound particles) — HCPCS code shown
    Additional HCPCS/Q-codesHCPCS
    J2778Lucentis (Ranibizumab) — HCPCS code shown
    J3590Miscellaneous codes used for several products (e.g., Menopur, Letybo)
    Q5147Pavblu (Aflibercept-ayyh) — Q-code shown
    Sample procedure-to-medication mappings from excerptHCPCS
    J9223Zepzelca (Lurbinectedin)
    J3399Zolgensma (Onasemnogene abeparvovec-xioi)
    J9332Vyvgart (Efgartigimod alfa)

    What Providers Must Do / How to Request Authorization

    Prior Authorization

    Prior authorization required for listed Part B drugs

    Providence Medicare Advantage Plans requires prior authorization for certain Medicare Part B–covered drugs; providers or the prescribing physician must obtain approval before the plan will agree to cover administration of the listed medications. If prior authorization is not obtained in advance, the drug might not be covered by the plan.

    Documentation Required

    Provider contact and support

    For questions or assistance with prior authorizations, contact Providence Medicare Advantage Plans at 503-574-8000 or 1-800-603-2340; TTY users should call 711. Phone support is available seven days a week from 8 a.m. to 8 p.m. Pacific Time (note: between April 1 and September 30 the plan is closed Saturdays and Sundays).

    Prior Authorization

    Key Columns, Links, and Definitions

    Prior authorization — definition / requirement
    DefinitionPrior authorization: requirement to obtain plan approval before the plan will agree to cover administration of certain Part B medications or related medical services.
    Who must obtainMember or their physician/provider must request prior authorization from Providence Medicare Advantage Plans.
    PurposeTo guide appropriate use of specified drugs (including specialty drugs injected or infused by a provider) and ensure coverage is consistent with plan criteria.
    Consequence of no approvalIf prior authorization is not obtained, the drug might not be covered by the plan.
    List column key — column structure explanation
    Column 1Medication Name — displays the drug name paired with its procedure/HCPCS code.
    Policy Summary
    PayerProvidence Health Plan
    PolicyProvidence Medicare Advantage Plans 2026 Prior Authorization Criteria for Part B Drugs
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateJul 1, 2026
    Next Review Date
    Key ActionObtain prior authorization from the plan before administering listed Part B drugs to ensure coverage.
    SourceLink
    On This Page
    Medicare Part B Drug Prior Authorization — Covered Criteria IndexHCPCS / CPT / Procedure Code ListingsWhat Providers Must Do / How to Request AuthorizationKey Columns, Links, and Definitions

    Drug‑specific prior authorization links (click to view)

    The policy lists individual Part B drugs alongside their HCPCS/Q/CPT procedure codes with 'Click to view' links that lead to the drug‑specific prior authorization criteria for each listed medication.

    • Each listed code entry includes a document link labeled 'Click to view' that points to the specific prior authorization criteria.
    Documentation Required

    Effective‑date notes on certain codes

    Some entries in the drug index include an effective‑date annotation (displayed as 'if after' dates or specific future dates) indicating the date the prior authorization requirement or listing applies to that procedure code.

    • Examples in the list show entries annotated 'if after 1/1/2026' or other dates (e.g., 7/1/2026, 4/1/2026, 6/1/2026).
    Prior Authorization

    Index of Part B drugs requiring prior authorization (procedure code → drug → link → effective date)

    The document provides an index mapping procedure code(s) to medication name and a document link (Click to view); the third column denotes an effective date when applicable (Procedure Code(s), 1 = Medication Name; 2 = Document Link; 3 = Effective Date if after 1/1/2026).

    • Example entries: J9223 = Zepzelca (Lurbinectedin) — Click to view; J3399 = Zolgensma (Onasemnogene abeparvovec‑xioi) — Click to view; J9332 = Vyvgart (Efgartigimod alfa) — Click to view.
    • Some index entries include an effective date in column 3 (e.g., Q5159 shows 6/1/2026; C9399/J3590 shows 7/1/2026).
    Column 2Document Link — labeled 'Click to view' and links to the drug-specific prior authorization policy criteria.
    Column 3Effective-date column — shows an effective date entry only when noted (e.g., 'if after 1/1/2026' or a specific future date).
    'Click to view' link — meaning
    Link label'Click to view' — denotes a hyperlink to the drug-specific prior authorization criteria/policy document for the listed medication.
    PlacementPresented in the Document Link (column 2) next to each medication/procedure code entry in the index.
    ScopeUsed across the Part B drug index for all entries that have detailed prior authorization criteria available via the link.
    Procedure code mapping conventions
    Mapping convention — field 1Procedure Code(s), 1 = Medication Name (the code is listed and followed by the drug name).
    Mapping convention — field 2Procedure Code(s), 2 = Document Link (the 'Click to view' link to the specific policy criteria).
    Mapping convention — field 3Procedure Code(s), 3 = Effective Date (only shown if the effective date is after 1/1/2026 or a specified future date).
    ExampleJ9223, 1 = Zepzelca (Lurbinectedin); J9223, 2 = Click to view; J9223, 3 = (blank unless an 'if after' date applies).